Therapeutic potential of deglycosylated antibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 25, 2013, Pages 10059-10060

  Crispin, Max ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; N ACETYL BETA GLUCOSAMINIDASE;

AMINO ACID SUBSTITUTION; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DEGLYCOSYLATION; EX VIVO STUDY; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; STREPTOCOCCUS PYOGENES;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, EXPERIMENTAL; IMMUNE TOLERANCE; IMMUNOGLOBULIN G;

EID: 84879298052     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1307776110     Document Type: Note

References (20)

1. Nandakumar KS, et al. (2013) Dominant suppression of inflammation by glycan-hydrolysed IgG. Proc Natl Acad Sci USA 110:10252-10257.
2. Collin M, Olsén A (2001) EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBOJ 20(12):3046-3055.
3. Collin M, Olsén A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 693(11):7187-7189.
4. Goodfellow JJ, et al. (2012) An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling. J Am Chem Soc 134(19):8030-8033.
5. Allhorn M, Olin AI, Nimmerjahn F, Collin M (2008) Human IgG/FcγR interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS One 3(1):e1413.
6. Sondermann P, Huber R, Oosthuizen V, Jacob U (2000) The 3.2-A crystal structure of the human IgG 1 Fc fragment-Fc gammaRIII complex. Nature 406(6793):267-273.
7. Baruah K, et al. (2012) Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions. J Mol Biol 420(1-2):1-7.
8. Borrok MJ, Jung ST, Kang TH, Monzingo AF, Georgiou G (2012) Revisiting the role of glycosylation in the structure of human IgG Fc. ACS Chem Biol 7(9):1596-1602.
9. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F (2008) In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci USA 105(39):15005-15009.
10. Benkhoucha M, et al. (2012) IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis. J Neuroinflammation 9:209.
11. Hirose M, et al. (2012) Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen. J Autoimmun 39(4):304-314.
12. Lood C, et al. (2012) IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment? Arthritis Rheum 64(8):2698-2706.
13. Nandakumar KS, et al. (2007) Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis. Eur J Immunol 37/(10):2973-2982.
14. Tradtrantip L, Ratelade J, Zhang H, Verkman AS (2013) Enzymatic deglycosylation converts pathogenic neuromyelitis optica antiaquaporin-4 immunoglobulin G into therapeutic antibody. Annals of Neurology 73(1):77-85.
15. Bakchoul T, et al. (2013) Inhibition of HPA-1a alloantibodymediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody: towards targeted treatment of fetalalloimmune thrombocytopenia. Blood, 10.1182/blood-2012-11-468561.
16. Kaneko Y Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313(5787):670-673.
17. Møller NP (1979) Fc-mediated immune precipitation. I. A new role of the Fc-portion of IgG. Immunology 38(3):631-640.
18. Easterbrook-Smith SB, Vandenberg RJ, Alden JR (1988) The role of Fc:Fc interactions in insoluble immune complex formation and complement activation. Mol Immunol 25(12):1331-1337.
19. Matsumiya S, et al. (2007) Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol 368(3):767-779.
20. Allhorn M, Collin M (2009) Sugar-free antibodies-The bacterial solution to autoimmunity? Annals of the New York Academy of Sciences 1173:664-669.